February
Why is there no Alzheimer’s cure? Lies, greed says a new book
In ‘Doctored’, Charles Piller, a science journalist, details how groupthink and dishonesty steered Alzheimer’s research off course.
January
As a doctor, here’s what I’ve learnt from my own Alzheimer’s disease
It is critical to manage Alzheimer’s disease in the early stages to postpone the onset of dementia. Don’t wait for the horses to get out of the barn.
September 2024
Alzheimer’s takes a financial toll long before diagnosis
People who develop dementia often begin falling behind on bills years earlier, research shows.
August 2024
The Australians who may soon pay more for aged care
Labor and the Coalition are drawing closer to an agreement on changes to aged care funding. This is what it would mean.
March 2024
How this virus may increase your risk of developing Alzheimer’s
Serious research is under way on whether treating this virus with antiviral medication could reduce the risk of Alzheimer’s.
January 2024
Alzheimer’s blood test a revolution for over-50s
A blood test that detects Alzheimer’s 10-15 years before a patient shows symptoms could be used to screen all over-50s.
March 2023
Why music causes memories to flood back
Music could be used as a therapy for dementia anxiety, stress and chronic pain, say researchers.
December 2022
Alzheimer’s drug may benefit some patients: new data
A clinical trial of an experimental Alzheimer’s drug suggests the treatment slowed cognitive decline but caused some patients to experience brain swelling.
November 2022
Second patient dies during Alzheimer’s drug trial
Shares in Eisai and Biogen, the two companies developing the drug, plunged after a second death was potentially linked to the breakthrough treatment.
October 2022
‘Scary’ evidence nose picking could increase risk of dementia
Australian researchers have shown that bacteria can travel through the nose and into the brain of mice, where it creates markers that are a telltale sign of Alzheimer’s disease.
September 2022
Alzheimer’s progression slowed by drug in major trial
Eisai and partner Biogen say their drug has slowed the pace of cognitive decline in people with early disease by 27 per cent when compared with a placebo.
July 2022
This famous 71-year-old scientist could hold the key to Alzheimer’s
Baroness Susan Greenfield is busy drumming up funding for her fourth start-up, which aims to identify the ageing disease long before symptoms appear.
June 2022
Breakthrough Alzheimer’s cure aims for human trials
Susan Greenfield has been doing the rounds talking to investors and potential collaborators about her breakthrough Alzheimer’s technology.
February 2022
The first steps to take when a person has dementia
The symptoms and diagnosis may be scary and overwhelming, but among the myriad questions is a raft of legal issues to consider.
December 2021
Study suggests Viagra can help prevent Alzheimer’s disease
A cutting-edge study, using big data and AI, has produced promising new evidence that Viagra-type drugs may help to prevent Alzheimer’s disease.
August 2021
How exercise may keep your memory sharp
The study, which was in mice, found that a hormone produced by muscles during exercise can cross into the brain and enhance the health and function of neurons, improving thinking and memory.
June 2021
New Alzheimer’s drug approved in US amid controversy
The world’s first drug to remove Alzheimer type plaques from the brain has been approved for use in the US but critics say there’s no conclusive proof this helps.
Biogen’s colossal risk on Alzheimer’s pays off
The pharmaceutical group poured years of effort into developing the therapy, called aducanumab, and was counting on it as its next big advance.
Myer family-backed Cogstate jumps 60pc on Alzheimer’s news
Cogstate shares jumped 60 per cent by midday because its brain health screening tests will benefit from the approval of the first every Alzheimer’s treatment drug in the United States.
Alzheimer’s drug approved in disease landmark
A controversial antibody therapy developed by Biogen was granted accelerated approval by the US Food and Drug Administration.